docetaxel hospira
hospira uk limited - docetakselis - koncentratas infuziniam tirpalui - 10 mg/ml - docetaxel
ivabradine grindeks
as grindeks - ivabradinas - plėvele dengtos tabletės - 7,5 mg - ivabradine
lopedium express
sandoz d.d. - loperamido hidrochloridas - kietosios kapsulės - 2 mg - loperamide
nexium
grünenthal gmbh - ezomeprazolas - skrandyje neirios tabletės - 40 mg; 20 mg - esomeprazole
rabeprazole actavis
teva b.v. - rabeprazolo natrio druska - skrandyje neirios tabletės - 10 mg; 20 mg - rabeprazole
rosuvastatin actavis
actavis group ptc ehf. - rozuvastatinas - plėvele dengtos tabletės - 40 mg; 10 mg; 5 mg; 20 mg - rosuvastatin
solifenacin pmcs
pro. med. cs praha a.s. - solifenacino sukcinatas - plėvele dengtos tabletės - 5 mg; 10 mg - solifenacin
vesicare
astellas pharma d.o.o. - solifenacino sukcinatas - geriamoji suspensija - 1 mg/ml; 5 mg; 10 mg - solifenacin
yzilan
sia ingen pharma - rabeprazolo natrio druska - skrandyje neirios tabletės - 10 mg; 20 mg - rabeprazole
lorviqua
pfizer europe ma eeig - lorlatinib - karcinoma, nesmulkiųjų ląstelių skausmas - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.